Invention Grant
- Patent Title: Compositions and methods for activation of NK cells killing of prostate cancer and breast cancer cells
-
Application No.: US16125091Application Date: 2018-09-07
-
Publication No.: US11111303B2Publication Date: 2021-09-07
- Inventor: Purunelloor A. Mathew , Stephen O. Mathew
- Applicant: UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER
- Applicant Address: US TX Ft. Worth
- Assignee: UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER
- Current Assignee: UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER
- Current Assignee Address: US TX Ft. Worth
- Agency: Norton Rose Fulbright US LLP
- Main IPC: C07K16/28
- IPC: C07K16/28 ; A61K47/68 ; A61K9/00 ; A61K51/10 ; A61P35/00 ; A61K39/00
Abstract:
Certain embodiments are directed to methods of treating LLT1 expressing cancer by administering to a subject having an LLT1 expressing cancer an LLT1 inhibitor.
Public/Granted literature
- US20190071505A1 COMPOSITIONS AND METHODS FOR ACTIVATION OF NK CELLS KILLING OF PROSTATE CANCER AND BREAST CANCER CELLS Public/Granted day:2019-03-07
Information query
